Media & Press2019-09-17T16:08:49-04:00

    Bexion Pharmaceuticals, Inc. to Present at the 2021 Discovery on Target Conference

    September 17, 2021|

    FOR IMMEDIATE RELEASE [Covington, KY---September 17, 2021] Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced today that Gilles Tapolsky PhD, MBA, Bexion’s Vice President, Pharmacology will be virtually presenting preclinical and clinical data of the Company’s lead compound, BXQ-350.  The presentation will be made at the Discovery on Target (DOT) Conference in the Immunology and ... Read More

      Bexion Pharmaceuticals, Inc. to Present at the 2021 Association for Cancer Immunotherapy (CIMT) Annual Meeting

      April 20, 2021|

      FOR IMMEDIATE RELEASE [Covington, KY---April 20, 2021] Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced today that an abstract submitted for an eTalk Session at the CIMT annual meeting to be held virtually May 10-12, 2021 has been chosen for presentation. Every year, the CIMT Annual Meeting connects the global cancer immunotherapy community in the ... Read More

        New Segment of Advancements to Focus on Breakthroughs in Targeted Cancer Cell Treatment

        April 12, 2021|

        Jupiter, FL— The award-winning series, Advancements with Ted Danson, will focus on an innovative, targeted approach to treating a range of diseases during 3Q/2021. Check local listings for more information. The diseases for which medicine offers few effective options – advanced cancer (or even early-stage cancer for certain types), neurodegenerative diseases and autoimmune diseases – persist because ... Read More

        All Press